<DOC>
	<DOCNO>NCT01067222</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety BF2.649 administer individual titration narcoleptic patient excessive daytime sleepiness ( EDS )</brief_summary>
	<brief_title>Efficacy Safety Study BF2.649 Treatment Excessive Daytime Sleepiness Narcolepsy</brief_title>
	<detailed_description>BF 2.649 , new experimental drug , significantly decrease , patient narcolepsy , excessive daytime sleepiness ( EDS ) evaluate Epworth Sleepiness Scale ( ESS ) , accord result two previous clinical study . The objective study determine efficacy safety BF2.649 administer escalate dose ( 10 , 20 40 mg/d ) narcoleptic patient excessive daytime sleepiness versus placebo Modafinil assess objective subjective measure include ESS , MWT , patient sleep diary . 60 patient narcolepsy without cataplexy include .</detailed_description>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>diagnosis narcolepsy without cataplexy patient need free discontinue psychostimulant medication least 14 day , patient severe cataplexy permit remain anticataplectic medication stable dos patient must adequate support comply entire study requirement Other condition Narcolepsy consider primary cause excessive daytime sleepiness Patients unable unwilling temporarily discontinue noauthorized drug substance Psychiatric neurological disorder psychosis dementia , bipolar illness , severe anxiety , clinical depression , history seizure disorder problem investigator 's opinion would preclude patient 's participation Current recent history substance abuse dependence disorder include alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Narcolepsy</keyword>
	<keyword>Excessive daytime Sleepiness</keyword>
	<keyword>Cataplexy</keyword>
	<keyword>Sleep Disorders</keyword>
	<keyword>Sleep attack</keyword>
	<keyword>Orphan Drug</keyword>
	<keyword>Pitolisant</keyword>
</DOC>